158.638 | The impact of transmission control measures during the first 50 days of the COVID-19 epidemic in China | An investigation of transmission control measures during the first 50 days of the COVID-19 epidemic in China | Tian, H.; Liu, Y.; Li, Y.; Wu, C.-H.; Chen, B.; Kraemer, M. U. G.; Li, B.; Cai, J.; Xu, B.; Yang, Q.; Wang, B.; Yang, P.; Cui, Y.; Song, Y.; Zheng, P.; Wang, Q.; Bjornstad, O. N.; Yang, R.; Grenfell, B.; Pybus, O.; Dye, C. | Tian, Huaiyu; Liu, Yonghong; Li, Yidan; Wu, Chieh-Hsi; Chen, Bin; Kraemer, Moritz U. G.; Li, Bingying; Cai, Jun; Xu, Bo; Yang, Qiqi; Wang, Ben; Yang, Peng; Cui, Yujun; Song, Yimeng; Zheng, Pai; Wang, Quanyi; Bjornstad, Ottar N.; Yang, Ruifu; Grenfell, Bryan T.; Pybus, Oliver G.; Dye, Christopher | 31/03/2020 | Science | 10.1126/science.abb6105 | CRESS, medRxiv, crossref |
63.393 | Clinical features and progression of acute respiratory distress syndrome in coronavirus disease 2019 | Association between platelet parameters and mortality in coronavirus disease 2019: Retrospective cohort study | Liu, Y.; Sun, W.; Li, J.; Chen, L.; Wang, Y.; Zhang, L.; Yu, L. | Liu, Yanli; Sun, Wenwu; Guo, Yanan; Chen, Liangkai; Zhang, Lijuan; Zhao, Su; Long, Ding; Yu, Li | 16/04/2020 | Platelets | 10.1080/09537104.2020.1754383 | False Positive |
73.965 | Association between 2019-nCoV transmission and N95 respirator use | Association between 2019-nCoV transmission and N95 respirator use | Wang, X.; Pan, Z.; Cheng, Z. | Wang, X.; Pan, Z.; Cheng, Z. | 03/03/2020 | Journal of Hospital Infection | 10.1016/j.jhin.2020.02.021 | CRESS, medRxiv, crossref |
101.593 | Clinical Features of COVID-19 Related Liver Damage | Clinical Features of COVID-19-Related Liver Functional Abnormality | Fan, Z.; Chen, L.; Li, J.; Tian, C.; Zhang, Y.; Huang, S.; Liu, Z.; Cheng, J. | Fan, Zhenyu; Chen, Liping; Li, Jun; Cheng, Xin; Yang, Jingmao; Tian, Cheng; Zhang, Yajun; Huang, Shaoping; Liu, Zhanju; Cheng, Jilin | 11/04/2020 | Clinical Gastroenterology and Hepatology | 10.1016/j.cgh.2020.04.002 | CRESS, medRxiv, crossref |
137.445 | Therapeutic effects of dipyridamole on COVID-19 patients with coagulation dysfunction | Potential therapeutic effects of dipyridamole in the severely ill patients with COVID-19 | Liu, X.; Li, Z.; Liu, S.; Chen, Z.; Zhao, Z.; Huang, Y.-y.; Zhang, Q.; Wang, J.; Shi, Y.; Xu, Y.; Sun, J.; Xian, H.; Fang, R.; Bai, F.; Ou, C.; Xiong, B.; Lew, A. M.; Cui, J.; Huang, H.; Zhao, J.; Hong, X.; Zhang, Y.; Zhou, F.; Luo, H.-B. | Liu, Xiaoyan; Li, Zhe; Liu, Shuai; Sun, Jing; Chen, Zhanghua; Jiang, Min; Zhang, Qingling; Wei, Yinghua; Wang, Xin; Huang, Yi-You; Shi, Yinyi; Xu, Yanhui; Xian, Huifang; Bai, Fan; Ou, Changxing; Xiong, Bei; Lew, Andrew M.; Cui, Jun; Fang, Rongli; Huang, Hui; Zhao, Jincun; Hong, Xuechuan; Zhang, Yuxia; Zhou, Fuling; Luo, Hai-Bin | 20/04/2020 | Acta Pharmaceutica Sinica B | 10.1016/j.apsb.2020.04.008 | CRESS, medRxiv, crossref |
102.840 | Early, low-dose and short-term application of corticosteroid treatment in patients with severe COVID-19 pneumonia: single-center experience from Wuhan, China | A retrospective cohort study of methylprednisolone therapy in severe patients with COVID-19 pneumonia | Wang, Y.; Jiang, W.; He, Q.; Wang, C.; Wang, B.; Zhou, P.; Dong, N.; Tong, Q. | Wang, Yin; Jiang, Weiwei; He, Qi; Wang, Cheng; Wang, Baoju; Zhou, Pan; Dong, Nianguo; Tong, Qiaoxia | 28/04/2020 | Signal Transduction and Targeted Therapy | 10.1038/s41392-020-0158-2 | CRESS |
136.228 | Impact assessment of non-pharmaceutical interventions against COVID-19 and influenza in Hong Kong: an observational study | Impact assessment of non-pharmaceutical interventions against coronavirus disease 2019 and influenza in Hong Kong: an observational study | Cowling, B. J.; Ali, S. T.; Ng, T. W. Y.; Tsang, T. K.; Li, J. C. M.; Fong, M. W.; Liao, Q.; Kwan, M. Y.; Lee, S. L.; Chiu, S. S.; Wu, J. T.; Wu, P.; Leung, G. M. | Cowling, Benjamin J; Ali, Sheikh Taslim; Ng, Tiffany W Y; Tsang, Tim K; Li, Julian C M; Fong, Min Whui; Liao, Qiuyan; Kwan, Mike YW; Lee, So Lun; Chiu, Susan S; Wu, Joseph T; Wu, Peng; Leung, Gabriel M | 17/04/2020 | The Lancet Public Health | 10.1016/s2468-2667(20)30090-6 | CRESS, medRxiv, crossref |
195.864 | The feasibility of convalescent plasma therapy in severe COVID-19 patients: a pilot study | Effectiveness of convalescent plasma therapy in severe COVID-19 patients | Duan, K.; Liu, B.; Li, C.; Zhang, H.; Yu, T.; Qu, J.; Zhou, M.; Chen, L.; Meng, S.; Hu, Y.; Peng, C.; Yuan, M.; Huang, J.; Wang, Z.; Yu, J.; Gao, X.; Wang, D.; Yu, X.; Li, L.; Zhang, J.; Wu, X.; Li, B.; Yu, Y.; Chen, W.; Peng, Y.; Hu, Y.; Lin, L.; Liu, X.; Huang, S.; Zhou, Z.; Zhang, L.; Wang, Y.; Zhang, Z.; Deng, K.; Xia, Z.; Gong, Q.; Zhang, W.; Zheng, X.; Liu, Y.; Yang, H.; Zhou, D.; Yu, D.; Hou, J.; Shi, Z.; Chen, S.; Chen, Z.; Zhang, X.-x.; Yang, X. | Duan, Kai; Liu, Bende; Li, Cesheng; Zhang, Huajun; Yu, Ting; Qu, Jieming; Zhou, Min; Chen, Li; Meng, Shengli; Hu, Yong; Peng, Cheng; Yuan, Mingchao; Huang, Jinyan; Wang, Zejun; Yu, Jianhong; Gao, Xiaoxiao; Wang, Dan; Yu, Xiaoqi; Li, Li; Zhang, Jiayou; Wu, Xiao; Li, Bei; Xu, Yanping; Chen, Wei; Peng, Yan; Hu, Yeqin; Lin, Lianzhen; Liu, Xuefei; Huang, Shihe; Zhou, Zhijun; Zhang, Lianghao; Wang, Yue; Zhang, Zhi; Deng, Kun; Xia, Zhiwu; Gong, Qin; Zhang, Wei; Zheng, Xiaobei; Liu, Ying; Yang, Huichuan; Zhou, Dongbo; Yu, Ding; Hou, Jifeng; Shi, Zhengli; Chen, Saijuan; Chen, Zhu; Zhang, Xinxin; Yang, Xiaoming | 07/04/2020 | Proceedings of the National Academy of Sciences | 10.1073/pnas.2004168117 | CRESS, medRxiv |
179.798 | Association between Prolonged Intermittent Renal Replacement Therapy and All-Cause Mortality in COVID-19 Patients Undergoing Invasive Mechanical Ventilation: a Retrospective Cohort Study | Association between Prolonged Intermittent Renal Replacement Therapy and All-Cause Mortality in COVID-19 Patients Undergoing Invasive Mechanical Ventilation: A Retrospective Cohort Study | Yang, Y.; Shi, J.; Ge, S.; Guo, S.; Xing, X.; Wang, Y.; Cheng, A.; Liu, Q.; Li, J.; Ning, Y.; He, F.; Xu, G. | Yang, Yi; Shi, Jia; Ge, Shuwang; Guo, Shuiming; Xing, Xue; Wang, Yanan; Cheng, Anying; Liu, Qingquan; Li, Junhua; Ning, Yong; He, Fan; Xu, Gang | 03/12/2020 | Blood Purification | 10.1159/000512099 | CRESS, medRxiv |
212.299 | Hydroxychloroquine and Azithromycin as a treatment of COVID-19: preliminary results of an open-label non-randomized clinical trial | Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial | GAUTRET, P.; LAGIER, J. C.; PAROLA, P.; HOANG, V. T.; MEDDED, L.; MAILHE, M.; DOUDIER, B.; COURJON, J.; GIORDANENGO, V.; ESTEVES VIEIRA, V.; TISSOT DUPONT, H.; HONORE, S.; COLSON, P.; CHABRIERE, E.; LA SCOLA, B.; ROLAIN, J. M.; BROUQUI, P.; RAOULT, D. | Gautret, Philippe; Lagier, Jean-Christophe; Parola, Philippe; Hoang, Van Thuan; Meddeb, Line; Mailhe, Morgane; Doudier, Barbara; Courjon, Johan; Giordanengo, Valérie; Vieira, Vera Esteves; Tissot Dupont, Hervé; Honoré, Stéphane; Colson, Philippe; Chabrière, Eric; La Scola, Bernard; Rolain, Jean-Marc; Brouqui, Philippe; Raoult, Didier | 20/03/2020 | International Journal of Antimicrobial Agents | 10.1016/j.ijantimicag.2020.105949 | CRESS, medRxiv, crossref |
175.255 | Hydroxychloroquine and Azithromycin as a treatment of COVID-19: preliminary results of an open-label non-randomized clinical trial | Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open label non-randomized clinical trial revisited | GAUTRET, P.; LAGIER, J. C.; PAROLA, P.; HOANG, V. T.; MEDDED, L.; MAILHE, M.; DOUDIER, B.; COURJON, J.; GIORDANENGO, V.; ESTEVES VIEIRA, V.; TISSOT DUPONT, H.; HONORE, S.; COLSON, P.; CHABRIERE, E.; LA SCOLA, B.; ROLAIN, J. M.; BROUQUI, P.; RAOULT, D. | Gautret, Philippe; Lagier, Jean-Christophe; Honoré, Stéphane; Hoang, Van Thuan; Colson, Philippe; Raoult, Didier | 04/01/2021 | International Journal of Antimicrobial Agents | 10.1016/j.ijantimicag.2020.106243 | CRESS |
155.934 | Hydroxychloroquine and Azithromycin as a treatment of COVID-19: preliminary results of an open-label non-randomized clinical trial | Effect of hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial, an update with an intention-to-treat analysis and clinical outcomes | GAUTRET, P.; LAGIER, J. C.; PAROLA, P.; HOANG, V. T.; MEDDED, L.; MAILHE, M.; DOUDIER, B.; COURJON, J.; GIORDANENGO, V.; ESTEVES VIEIRA, V.; TISSOT DUPONT, H.; HONORE, S.; COLSON, P.; CHABRIERE, E.; LA SCOLA, B.; ROLAIN, J. M.; BROUQUI, P.; RAOULT, D. | Gautret, Philippe; Hoang, Van Thuan; Lagier, Jean-Christophe; Raoult, Didier | 04/01/2021 | International Journal of Antimicrobial Agents | 10.1016/j.ijantimicag.2020.106239 | CRESS |
143.491 | Hydroxychloroquine and Azithromycin as a treatment of COVID-19: preliminary results of an open-label non-randomized clinical trial | Response to effect estimation of hydroxychloroquine for COVID-19: a secondary analysis of an open label non-randomized clinical trial. | GAUTRET, P.; LAGIER, J. C.; PAROLA, P.; HOANG, V. T.; MEDDED, L.; MAILHE, M.; DOUDIER, B.; COURJON, J.; GIORDANENGO, V.; ESTEVES VIEIRA, V.; TISSOT DUPONT, H.; HONORE, S.; COLSON, P.; CHABRIERE, E.; LA SCOLA, B.; ROLAIN, J. M.; BROUQUI, P.; RAOULT, D. | Gautret, Philippe; Hoang, Van Thuan; Lagier, Jean-Christophe; Raoult, Didier | 04/01/2021 | International Journal of Antimicrobial Agents | 10.1016/j.ijantimicag.2020.106237 | CRESS |
137.515 | Hydroxychloroquine and Azithromycin as a treatment of COVID-19: preliminary results of an open-label non-randomized clinical trial | Clinical efficacy and safety profile of hydroxychloroquine and azithromycin against COVID-19 | GAUTRET, P.; LAGIER, J. C.; PAROLA, P.; HOANG, V. T.; MEDDED, L.; MAILHE, M.; DOUDIER, B.; COURJON, J.; GIORDANENGO, V.; ESTEVES VIEIRA, V.; TISSOT DUPONT, H.; HONORE, S.; COLSON, P.; CHABRIERE, E.; LA SCOLA, B.; ROLAIN, J. M.; BROUQUI, P.; RAOULT, D. | Gautret, Philippe; Lagier, Jean-Christophe; Honoré, Stéphane; Hoang, Van Thuan; Raoult, Didier | 04/01/2021 | International Journal of Antimicrobial Agents | 10.1016/j.ijantimicag.2020.106242 | - |
130.499 | Hydroxychloroquine and Azithromycin as a treatment of COVID-19: preliminary results of an open-label non-randomized clinical trial | Safety profile of hydroxychloroquine and azithromycin combined treatment in COVID-19 patients | GAUTRET, P.; LAGIER, J. C.; PAROLA, P.; HOANG, V. T.; MEDDED, L.; MAILHE, M.; DOUDIER, B.; COURJON, J.; GIORDANENGO, V.; ESTEVES VIEIRA, V.; TISSOT DUPONT, H.; HONORE, S.; COLSON, P.; CHABRIERE, E.; LA SCOLA, B.; ROLAIN, J. M.; BROUQUI, P.; RAOULT, D. | Gautret, Philippe; Honoré, Stéphane; Lagier, Jean-Christophe; Raoult, Didier | 04/01/2021 | International Journal of Antimicrobial Agents | 10.1016/j.ijantimicag.2020.106236 | - |
126.985 | Hydroxychloroquine and Azithromycin as a treatment of COVID-19: preliminary results of an open-label non-randomized clinical trial | Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: A pilot observational study | GAUTRET, P.; LAGIER, J. C.; PAROLA, P.; HOANG, V. T.; MEDDED, L.; MAILHE, M.; DOUDIER, B.; COURJON, J.; GIORDANENGO, V.; ESTEVES VIEIRA, V.; TISSOT DUPONT, H.; HONORE, S.; COLSON, P.; CHABRIERE, E.; LA SCOLA, B.; ROLAIN, J. M.; BROUQUI, P.; RAOULT, D. | Gautret, Philippe; Lagier, Jean-Christophe; Parola, Philippe; Hoang, Van Thuan; Meddeb, Line; Sevestre, Jacques; Mailhe, Morgane; Doudier, Barbara; Aubry, Camille; Amrane, Sophie; Seng, Piseth; Hocquart, Marie; Eldin, Carole; Finance, Julie; Vieira, Vera Esteves; Tissot-Dupont, Hervé Tissot; Honoré, Stéphane; Stein, Andreas; Million, Matthieu; Colson, Philippe; La Scola, Bernard; Veit, Véronique; Jacquier, Alexis; Deharo, Jean-Claude; Drancourt, Michel; Fournier, Pierre Edouard; Rolain, Jean-Marc; Brouqui, Philippe; Raoult, Didier | 11/04/2020 | Travel Medicine and Infectious Disease | 10.1016/j.tmaid.2020.101663 | - |
115.854 | Hydroxychloroquine and Azithromycin as a treatment of COVID-19: preliminary results of an open-label non-randomized clinical trial | Response to the use of hydroxychloroquine in combination with azithromycin for patients with COVID-19 is not supported by recent literature. | GAUTRET, P.; LAGIER, J. C.; PAROLA, P.; HOANG, V. T.; MEDDED, L.; MAILHE, M.; DOUDIER, B.; COURJON, J.; GIORDANENGO, V.; ESTEVES VIEIRA, V.; TISSOT DUPONT, H.; HONORE, S.; COLSON, P.; CHABRIERE, E.; LA SCOLA, B.; ROLAIN, J. M.; BROUQUI, P.; RAOULT, D. | Gautret, Philippe; Hoang, Van Thuan; Honoré, Stéphane; Roussel, Yanis; Million, Matthieu; Lagier, Jean-Christophe; Raoult, Didier | 04/01/2021 | International Journal of Antimicrobial Agents | 10.1016/j.ijantimicag.2020.106241 | - |
110.700 | Hydroxychloroquine and Azithromycin as a treatment of COVID-19: preliminary results of an open-label non-randomized clinical trial | Response to advances statistical methods and designs for clinical trials for COVID-19 | GAUTRET, P.; LAGIER, J. C.; PAROLA, P.; HOANG, V. T.; MEDDED, L.; MAILHE, M.; DOUDIER, B.; COURJON, J.; GIORDANENGO, V.; ESTEVES VIEIRA, V.; TISSOT DUPONT, H.; HONORE, S.; COLSON, P.; CHABRIERE, E.; LA SCOLA, B.; ROLAIN, J. M.; BROUQUI, P.; RAOULT, D. | Gautret, Philippe; Hoang, Van Thuan; Lagier, Jean-Christophe; Raoult, Didier | 04/01/2021 | International Journal of Antimicrobial Agents | 10.1016/j.ijantimicag.2020.106235 | - |
155.564 | Favipiravir versus Arbidol for COVID-19: A Randomized Clinical Trial | Favipiravir Versus Arbidol for Clinical Recovery Rate in Moderate and Severe Adult COVID-19 Patients: A Prospective, Multicenter, Open-Label, Randomized Controlled Clinical Trial | Chen, C.; Zhang, Y.; Huang, J.; Yin, P.; Cheng, Z.; Wu, J.; Chen, S.; Zhang, Y.; Chen, B.; Lu, M.; Luo, Y.; Ju, L.; Zhang, J.; Wang, X. | Chen, Chang; Zhang, Yi; Huang, Jianying; Yin, Ping; Cheng, Zhenshun; Wu, Jianyuan; Chen, Song; Zhang, Yongxi; Chen, Bo; Lu, Mengxin; Luo, Yongwen; Ju, Lingao; Zhang, Jingyi; Wang, Xinghuan | 04/09/2021 | Frontiers in Pharmacology | 10.3389/fphar.2021.683296 | CRESS, medRxiv |
193.945 | An exploratory randomized controlled study on the efficacy and safety of lopinavir/ritonavir or arbidol treating adult patients hospitalized with mild/moderate COVID-19 (ELACOI) | Efficacy and Safety of Lopinavir/Ritonavir or Arbidol in Adult Patients with Mild/Moderate COVID-19: An Exploratory Randomized Controlled Trial | Li, Y.; Xie, Z.; Lin, W.; Cai, W.; Wen, C.; Guan, Y.; Mo, X.; Wang, J.; Wang, Y.; Peng, P.; Chen, X.; Hong, W.; Xiao, G.; Liu, J.; Zhang, L.; Hu, F.; Li, F.; Li, F.; Zhang, F.; Deng, X.; Li, L. | Li, Yueping; Xie, Zhiwei; Lin, Weiyin; Cai, Weiping; Wen, Chunyan; Guan, Yujuan; Mo, Xiaoneng; Wang, Jian; Wang, Yaping; Peng, Ping; Chen, Xudan; Hong, Wenxin; Xiao, Guangming; Liu, Jinxin; Zhang, Lieguang; Hu, Fengyu; Li, Feng; Zhang, Fuchun; Deng, Xilong; Li, Linghua | 19/05/2020 | Med | 10.1016/j.medj.2020.04.001 | CRESS, medRxiv |
121.271 | Meplazumab treats COVID-19 pneumonia: an open-labelled, concurrent controlled add-on clinical trial | Safety and efficacy of meplazumab in healthy volunteers and COVID-19 patients: a randomized phase 1 and an exploratory phase 2 trial | Bian, H.; Zheng, Z.-H.; Wei, D.; Zhang, Z.; Kang, W.-Z.; Hao, C.-Q.; Dong, K.; Kang, W.; Xia, J.-L.; Miao, J.-L.; Xie, R.-H.; Wang, B.; Sun, X.-X.; Yang, X.-M.; Lin, P.; Geng, J.-J.; Wang, K.; Cui, H.-Y.; Zhang, K.; Chen, X.-C.; Tang, H.; Du, H.; Yao, N.; Liu, S.-S.; Liu, L.-N.; Zhang, Z.; Gao, Z.-W.; Nan, G.; Wang, Q.-Y.; Lian, J.-Q.; Chen, Z.-N.; Zhu, P. | Bian, Huijie; Zheng, Zhao-Hui; Wei, Ding; Wen, Aidong; Zhang, Zheng; Lian, Jian-Qi; Kang, Wen-Zhen; Hao, Chun-Qiu; Wang, Jing; Xie, Rong-Hua; Dong, Ke; Xia, Jie-Lai; Miao, Jin-Lin; Kang, Wen; Li, Guoquan; Zhang, Di; Zhang, Mingru; Sun, Xiu-Xuan; Ding, Likun; Zhang, Kui; Jia, Junfeng; Ding, Jin; Li, Zhiqin; Jia, Yanyan; Liu, Lin-Na; Zhang, Zhe; Gao, Zhao-Wei; Du, Hong; Yao, Na; Wang, Qing; Wang, Ke; Geng, Jie-Jie; Wang, Bin; Guo, Ting; Chen, Ruo; Zhu, Yu-Meng; Wang, Li-Juan; He, Qian; Yao, Rui-Rui; Shi, Ying; Yang, Xiang-Min; Zhou, Jian-Sheng; Ma, Yi-Nan; Wang, Ya-Tao; Liang, Xue; Huo, Fei; Wang, Zhe; Zhang, Yang; Yang, Xu; Zhang, Ye; Gao, Lu-Hua; Wang, Ling; Chen, Xiao-Chun; Tang, Hao; Liu, Shuang-Shuang; Wang, Qing-Yi; Chen, Zhi-Nan; Zhu, Ping | 17/05/2021 | Signal Transduction and Targeted Therapy | 10.1038/s41392-021-00603-6 | False Positive |
95.399 | Meplazumab treats COVID-19 pneumonia: an open-labelled, concurrent controlled add-on clinical trial | Meplazumab in hospitalized adults with severe COVID-19 (DEFLECT): a multicenter, seamless phase 2/3, randomized, third-party double-blind clinical trial | Bian, H.; Zheng, Z.-H.; Wei, D.; Zhang, Z.; Kang, W.-Z.; Hao, C.-Q.; Dong, K.; Kang, W.; Xia, J.-L.; Miao, J.-L.; Xie, R.-H.; Wang, B.; Sun, X.-X.; Yang, X.-M.; Lin, P.; Geng, J.-J.; Wang, K.; Cui, H.-Y.; Zhang, K.; Chen, X.-C.; Tang, H.; Du, H.; Yao, N.; Liu, S.-S.; Liu, L.-N.; Zhang, Z.; Gao, Z.-W.; Nan, G.; Wang, Q.-Y.; Lian, J.-Q.; Chen, Z.-N.; Zhu, P. | Bian, Huijie; Chen, Liang; Zheng, Zhao-Hui; Sun, Xiu-Xuan; Geng, Jie-Jie; Chen, Ruo; Wang, Ke; Yang, Xu; Chen, Shi-Rui; Chen, Si-Yu; Xie, Rong-Hua; Zhang, Kui; Miao, Jin-Lin; Jia, Jun-Feng; Tang, Hao; Liu, Shuang-Shuang; Shi, Hong-Wei; Yang, Yong; Chen, Xiao-Chun; Malhotra, Vinay; Nasir, Nosheen; Khanum, Iffat; Mahmood, Faisal; Hamid, Saeed; Stadnik, Claudio Marcel Berdun; Itinose, Kengi; de Oliveira, Caroline Cândida Carvalho; Dusilek, Cesar; Rivabem, Lucas; Cavalcante, Adilson Joaquim Westheimer; Lopes, Suzara Souto; Saporito, Wladmir Faustino; Fucci, Fábio José Concilio; Simon-Campos, Jesus Abraham; Wang, Ling; Liu, Lin-Na; Wang, Qing-Yi; Wei, Ding; Zhang, Zheng; Chen, Zhi-Nan; Zhu, Ping | 30/01/2023 | Signal Transduction and Targeted Therapy | 10.1038/s41392-023-01323-9 | False Positive |
149.777 | First Clinical Study Using HCV Protease Inhibitor Danoprevir to Treat Naive and Experienced COVID-19 Patients | First clinical study using HCV protease inhibitor danoprevir to treat COVID-19 patients | Chen, H.; Zhang, Z.; Wang, L.; Huang, Z.; Gong, F.; Li, X.; Chen, Y.; WU, J. J. | Chen, Hongyi; Zhang, Zhicheng; Wang, Li; Huang, Zhihua; Gong, Fanghua; Li, Xiaodong; Chen, Yahong; Wu, Jinzi J. | 23/11/2020 | Medicine | 10.1097/md.0000000000023357 | CRESS, medRxiv |
142.248 | Factors associated with prolonged viral shedding and impact of Lopinavir/Ritonavir treatment in patients with SARS-CoV-2 infection | Factors associated with prolonged viral shedding and impact of lopinavir/ritonavir treatment in hospitalised non-critically ill patients with SARS-CoV-2 infection | Yan, D.; Liu, X.-y.; Zhu, Y.-n.; Huang, L.; Dan, B.-t.; Zhang, G.-j.; Gao, Y.-h. | Yan, Dan; Liu, Xiao-Yan; Zhu, Ya-nan; Huang, Li; Dan, Bi-tang; Zhang, Guo-jun; Gao, Yong-hua | 19/05/2020 | European Respiratory Journal | 10.1183/13993003.00799-2020 | CRESS, medRxiv, crossref |
155.403 | Risk Factors Associated with Clinical Outcomes in 323 COVID-19 Patients in Wuhan, China | Risk Factors Associated With Clinical Outcomes in 323 Coronavirus Disease 2019 (COVID-19) Hospitalized Patients in Wuhan, China | Hu, L.; Chen, S.; Fu, Y.; Gao, Z.; Long, H.; Ren, H.-w.; Zuo, Y.; Li, H.; Wang, J.; Xv, Q.-b.; Yu, W.-x.; Liu, J.; Shao, C.; Hao, J.-j.; Wang, C.-z.; Ma, Y.; Wang, Z.; Yanagihara, R.; Wang, J.-m.; Deng, Y. | Hu, Ling; Chen, Shaoqiu; Fu, Yuanyuan; Gao, Zitong; Long, Hui; Ren, Hong-wei; Zuo, Yi; Wang, Jie; Li, Huan; Xu, Qing-bang; Yu, Wen-xiong; Liu, Jia; Shao, Chen; Hao, Jun-jie; Wang, Chuan-zhen; Ma, Yao; Wang, Zhanwei; Yanagihara, Richard; Deng, Youping | 02/05/2020 | Clinical Infectious Diseases | 10.1093/cid/ciaa539 | CRESS, medRxiv |
163.369 | Medical treatment of 55 patients with COVID-19 from seven cities in northeast China who fully recovered: a single-center, retrospective, observational study | Medical treatment of 55 patients with COVID-19 from seven cities in northeast China who fully recovered | Fan, L.; Liu, C.; Li, N.; Liu, H.; Gu, Y.; Liu, Y.; Chen, Y. | Fan, Lichao; Liu, Huan; Li, Na; Liu, Chang; Gu, Ye; Liu, Yongyu; Chen, Yu | 14/01/2021 | Medicine | 10.1097/md.0000000000023923 | CRESS, medRxiv |
159.174 | The potential of low molecular weight heparin to mitigate cytokine storm in severe COVID-19 patients: a retrospective clinical study | The Potential of Low Molecular Weight Heparin to Mitigate Cytokine Storm in Severe COVID‐19 Patients: A Retrospective Cohort Study | SHI, C.; WANG, C.; WANG, H.; YANG, C.; CAI, F.; ZENG, F.; CHENG, F.; LIU, Y.; ZHOU, T.; DENG, B.; Vlodavsky, I.; LI, J.; ZHANG, Y. | Shi, Chen; Wang, Cong; Wang, Hanxiang; Yang, Chao; Cai, Fei; Zeng, Fang; Cheng, Fang; Liu, Yihui; Zhou, Taotao; Deng, Bin; Vlodavsky, Israel; Li, Jin‐Ping; Zhang, Yu | 03/09/2020 | Clinical and Translational Science | 10.1111/cts.12880 | CRESS, medRxiv |
66.634 | The potential of low molecular weight heparin to mitigate cytokine storm in severe COVID-19 patients: a retrospective clinical study | Comprehensive Landscape of Heparin Therapy for COVID-19 | SHI, C.; WANG, C.; WANG, H.; YANG, C.; CAI, F.; ZENG, F.; CHENG, F.; LIU, Y.; ZHOU, T.; DENG, B.; Vlodavsky, I.; LI, J.; ZHANG, Y. | Shi, Chen; Tingting, Wu; Li, Jin-Ping; Sullivan, Mitchell A.; Wang, Cong; Wang, Hanxiang; Deng, Bin; Zhang, Yu | 23/10/2020 | Carbohydrate Polymers | 10.1016/j.carbpol.2020.117232 | - |
176.939 | Angiotensin II Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors Usage is Associated with Improved Inflammatory Status and Clinical Outcomes in COVID-19 Patients With Hypertension | Effects of Angiotensin II Receptor Blockers and ACE (Angiotensin-Converting Enzyme) Inhibitors on Virus Infection, Inflammatory Status, and Clinical Outcomes in Patients With COVID-19 and Hypertension | Yang, G.; Tan, Z.; Zhou, L.; Yang, M.; Peng, L.; Liu, J.; Cai, J.; Yang, R.; Han, J.; Huang, Y.; He, S. | Yang, Guang; Tan, Zihu; Zhou, Ling; Yang, Min; Peng, Lang; Liu, Jinjin; Cai, Jingling; Yang, Ru; Han, Junyan; Huang, Yafei; He, Shaobin | 29/04/2020 | Hypertension | 10.1161/hypertensionaha.120.15143 | CRESS, medRxiv |
158.801 | Social distancing to slow the U.S. COVID-19 epidemic: longitudinal pretest-posttest comparison group study | Correction: Social distancing to slow the US COVID-19 epidemic: Longitudinal pretest–posttest comparison group study | Siedner, M. J.; Harling, G.; Reynolds, Z.; Gilbert, R. F.; Haneuse, S.; Venkataramani, A.; Tsai, A. C. | Siedner, Mark J.; Harling, Guy; Reynolds, Zahra; Gilbert, Rebecca F.; Haneuse, Sebastien; Venkataramani, Atheendar S.; Tsai, Alexander C. | 06/10/2020 | PLOS Medicine | 10.1371/journal.pmed.1003376 | GC |
157.219 | Social distancing to slow the U.S. COVID-19 epidemic: longitudinal pretest-posttest comparison group study | Social distancing to slow the US COVID-19 epidemic: Longitudinal pretest–posttest comparison group study | Siedner, M. J.; Harling, G.; Reynolds, Z.; Gilbert, R. F.; Haneuse, S.; Venkataramani, A.; Tsai, A. C. | Siedner, Mark J.; Harling, Guy; Reynolds, Zahra; Gilbert, Rebecca F.; Haneuse, Sebastien; Venkataramani, Atheendar S.; Tsai, Alexander C. | 11/08/2020 | PLOS Medicine | 10.1371/journal.pmed.1003244 | CRESS, medRxiv, crossref |
163.521 | Mandated Bacillus Calmette-Guerin (BCG) vaccination predicts flattened curves for the spread of COVID-19 | Mandated Bacillus Calmette-Guérin (BCG) vaccination predicts flattened curves for the spread of COVID-19 | Berg, M. K.; Yu, Q.; Salvador, C. E.; Melani, I.; Kitayama, S. | Berg, Martha K.; Yu, Qinggang; Salvador, Cristina E.; Melani, Irene; Kitayama, Shinobu | 05/08/2020 | Science Advances | 10.1126/sciadv.abc1463 | CRESS, medRxiv, crossref |
113.061 | Interferon-a2b treatment for COVID-19 | Interferon-α2b Treatment for COVID-19 | Zhou, Q.; Wei, X.-S.; Xiang, X.; Wang, X.; Wang, Z.-H.; Chen, V.; Shannon, C. P.; Tebbutt, S. J.; Kollmann, T. R.; Fish, E. N. | Zhou, Qiong; Chen, Virginia; Shannon, Casey P.; Wei, Xiao-Shan; Xiang, Xuan; Wang, Xu; Wang, Zi-Hao; Tebbutt, Scott J.; Kollmann, Tobias R.; Fish, Eleanor N. | 15/05/2020 | Frontiers in Immunology | 10.3389/fimmu.2020.01061 | CRESS, medRxiv, crossref |
111.933 | Interferon-a2b treatment for COVID-19 | Corrigendum: Interferon-α2b Treatment for COVID-19 | Zhou, Q.; Wei, X.-S.; Xiang, X.; Wang, X.; Wang, Z.-H.; Chen, V.; Shannon, C. P.; Tebbutt, S. J.; Kollmann, T. R.; Fish, E. N. | Zhou, Qiong; Chen, Virginia; Shannon, Casey P.; Wei, Xiao-Shan; Xiang, Xuan; Wang, Xu; Wang, Zi-Hao; Tebbutt, Scott J.; Kollmann, Tobias R.; Fish, Eleanor N. | 27/10/2020 | Frontiers in Immunology | 10.3389/fimmu.2020.615275 | GC |
76.034 | Interferon-a2b treatment for COVID-19 | Interferon-α2b Treatment for COVID-19 Is Associated with Improvements in Lung Abnormalities | Zhou, Q.; Wei, X.-S.; Xiang, X.; Wang, X.; Wang, Z.-H.; Chen, V.; Shannon, C. P.; Tebbutt, S. J.; Kollmann, T. R.; Fish, E. N. | Zhou, Qiong; MacArthur, Michael; He, Xinliang; Wei, Xiaoshan; Zarin, Payam; Hanna, Bola; Wang, Zi-Hao; Xiang, Xuan; Fish, Eleanor | 31/12/2020 | Viruses | 10.3390/v13010044 | - |
30.629 | Connecting BCG Vaccination and COVID-19: Additional Data | BCG vaccination status and its relationship to islet autoantibodies in children with type 1 diabetes | Dayal, D.; Gupta, S. | Dayal, Devi; Rohilla, Latika; Kaur, Gurpreet; Walia, Priyanka; Kumar, Rakesh; Yadav, Jaivinder | 12/01/2022 | Indian Journal of Endocrinology and Metabolism | 10.4103/ijem.ijem_257_21 | False Positive |
115.221 | Adjuvant corticosteroid therapy for critically ill patients with COVID-19 | Adjuvant corticosteroid therapy for critically ill patients with COVID-19 | Lu, X.; Chen, T.; Wang, Y.; Wang, J.; Zhang, B.; Li, Y.; Yan, F. | Lu, Xiaofan; Chen, Taige; Wang, Yang; Wang, Jun; Yan, Fangrong | 19/05/2020 | Critical Care | 10.1186/s13054-020-02964-w | CRESS, medRxiv, crossref |
76.863 | Adjuvant corticosteroid therapy for critically ill patients with COVID-19 | Classification of COVID-19 in intensive care patients | Lu, X.; Chen, T.; Wang, Y.; Wang, J.; Zhang, B.; Li, Y.; Yan, F. | Lu, Xiaofan; Wang, Yang; Chen, Taige; Wang, Jun; Yan, Fangrong | 09/07/2020 | Critical Care | 10.1186/s13054-020-03127-7 | - |
69.378 | Adjuvant corticosteroid therapy for critically ill patients with COVID-19 | Continuously available ratio of SpO2/FiO2 serves as a noninvasive prognostic marker for intensive care patients with COVID-19 | Lu, X.; Chen, T.; Wang, Y.; Wang, J.; Zhang, B.; Li, Y.; Yan, F. | Lu, Xiaofan; Jiang, Liyun; Chen, Taige; Wang, Yang; Zhang, Bing; Hong, Yizhou; Wang, Jun; Yan, Fangrong | 22/07/2020 | Respiratory Research | 10.1186/s12931-020-01455-4 | - |
233.096 | Chloroquine diphosphate in two different dosages as adjunctive therapy of hospitalized patients with severe respiratory syndrome in the context of coronavirus (SARS-CoV-2) infection: Preliminary safety results of a randomized, double-blinded, phase IIb clinical trial (CloroCovid-19 Study) | Effect of High vs Low Doses of Chloroquine Diphosphate as Adjunctive Therapy for Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection | Borba, M. G. S.; Val, F. d. A.; Sampaio, V. S.; Alexandre, M. A. A.; Melo, G. C.; Brito, M.; Mourão, M. P. G.; Brito Sousa, J. D.; Baia-da-Silva, D. C.; Guerra, M. V. F.; Hajjar, L. A.; Pinto, R. C.; Balieiro, A. A. S.; Naveca, F. G.; Xavier, M. S.; Salomao, A.; Siqueira, A. M.; Schwarzbolt, A.; Croda, J. H. R.; Nogueira, M. L.; Romero, G. A. S.; Bassat, Q.; Fontes, C. J.; Albuquerque, B. C.; Daniel-Ribeiro, C. T.; Monteiro, W. M.; Lacerda, M. V. G.; CloroCovid-19 Team, | Borba, Mayla Gabriela Silva; Val, Fernando Fonseca Almeida; Sampaio, Vanderson Souza; Alexandre, Marcia Almeida Araújo; Melo, Gisely Cardoso; Brito, Marcelo; Mourão, Maria Paula Gomes; Brito-Sousa, José Diego; Baía-da-Silva, Djane; Guerra, Marcus Vinitius Farias; Hajjar, Ludhmila Abrahão; Pinto, Rosemary Costa; Balieiro, Antonio Alcirley Silva; Pacheco, Antônio Guilherme Fonseca; Santos, James Dean Oliveira; Naveca, Felipe Gomes; Xavier, Mariana Simão; Siqueira, André Machado; Schwarzbold, Alexandre; Croda, Júlio; Nogueira, Maurício Lacerda; Romero, Gustavo Adolfo Sierra; Bassat, Quique; Fontes, Cor Jesus; Albuquerque, Bernardino Cláudio; Daniel-Ribeiro, Cláudio-Tadeu; Monteiro, Wuelton Marcelo; Lacerda, Marcus Vinícius Guimarães; for the CloroCovid-19 Team | 24/04/2020 | JAMA Network Open | 10.1001/jamanetworkopen.2020.8857 | CRESS, medRxiv, crossref |
113.792 | The Immediate Effect of COVID-19 Policies on Social Distancing Behavior in the United States | The Immediate Effect of COVID-19 Policies on Social-Distancing Behavior in the United States | Abouk, R.; Heydari, B. | Abouk, Rahi; Heydari, Babak | 13/01/2021 | Public Health Reports | 10.1177/0033354920976575 | CRESS, medRxiv |
169.010 | Calcium channel blocker amlodipine besylate is associated with reduced case fatality rate of COVID-19 patients with hypertension | Author Correction: Calcium channel blocker amlodipine besylate therapy is associated with reduced case fatality rate of COVID-19 patients with hypertension | Zhang, L.; Sun, Y.; Zeng, H.-L.; Peng, Y.; Jiang, X.; Shang, W.-J.; Wu, Y.; Li, S.; Zhang, Y.-L.; Yang, L.; Chen, H.; Jin, R.; Liu, W.; Li, H.; Peng, K.; Xiao, G. | Zhang, Lei-Ke; Sun, Yuan; Zeng, Haolong; Wang, Qingxing; Jiang, Xiaming; Shang, Wei-Juan; Wu, Yan; Li, Shufen; Zhang, Yu-Lan; Hao, Zhao-Nian; Chen, Hongbo; Jin, Runming; Liu, Wei; Li, Hao; Peng, Ke; Xiao, Gengfu | 03/05/2021 | Cell Discovery | 10.1038/s41421-021-00267-0 | GC |
169.010 | Calcium channel blocker amlodipine besylate is associated with reduced case fatality rate of COVID-19 patients with hypertension | Calcium channel blocker amlodipine besylate therapy is associated with reduced case fatality rate of COVID-19 patients with hypertension | Zhang, L.; Sun, Y.; Zeng, H.-L.; Peng, Y.; Jiang, X.; Shang, W.-J.; Wu, Y.; Li, S.; Zhang, Y.-L.; Yang, L.; Chen, H.; Jin, R.; Liu, W.; Li, H.; Peng, K.; Xiao, G. | Zhang, Lei-Ke; Sun, Yuan; Zeng, Haolong; Wang, Qingxing; Jiang, Xiaming; Shang, Wei-Juan; Wu, Yan; Li, Shufen; Zhang, Yu-Lan; Hao, Zhao-Nian; Chen, Hongbo; Jin, Runming; Liu, Wei; Li, Hao; Peng, Ke; Xiao, Gengfu | 22/12/2020 | Cell Discovery | 10.1038/s41421-020-00235-0 | CRESS, medRxiv |
114.450 | Exercising caution in correlating COVID-19 incidence and mortality rates with BCG vaccination policies due to variable rates of SARS CoV-2 testing | Protection against SARS-CoV-2 by BCG vaccination is not supported by epidemiological analyses | Hensel, J.; McGrail, D. J.; McAndrews, K. M.; Dowlatshahi, D.; LeBleu, V. S.; Kalluri, R. | Hensel, Janine; McAndrews, Kathleen M.; McGrail, Daniel J.; Dowlatshahi, Dara P.; LeBleu, Valerie S.; Kalluri, Raghu | 27/10/2020 | Scientific Reports | 10.1038/s41598-020-75491-x | CRESS |
125.097 | The Use of Adjuvant Therapy in Preventing Progression to Severe Pneumonia in Patients with Coronavirus Disease 2019: A Multicenter Data Analysis | Clinical Factors Associated with Progression and Prolonged Viral Shedding in COVID-19 Patients: A Multicenter Study | Feng, Z.; Li, J.; Yao, S.; Yu, Q.; Zhou, W.; Mao, X.; Li, H.; Kang, W.; Ouyang, X.; Mei, J.; Zeng, Q.; Liu, J.; Ma, X.; Rong, P.; Wang, W. | Feng, Zhichao; Li, Jennifer; Yao, Shanhu; Yu, Qizhi; Zhou, Wenming; Mao, Xiaowen; Li, Huiling; Kang, Wendi; Ouyang, Xin; Mei, Ji; Zeng, Qiuhua; Liu, Jincai; Ma, Xiaoqian; Rong, Pengfei; Wang, Wei | 22/09/2020 | Aging and disease | 10.14336/ad.2020.0630 | CRESS |
67.184 | The Use of Adjuvant Therapy in Preventing Progression to Severe Pneumonia in Patients with Coronavirus Disease 2019: A Multicenter Data Analysis | Association of Paraspinal Muscle Measurements on Chest Computed Tomography With Clinical Outcomes in Patients With Severe Coronavirus Disease 2019 | Feng, Z.; Li, J.; Yao, S.; Yu, Q.; Zhou, W.; Mao, X.; Li, H.; Kang, W.; Ouyang, X.; Mei, J.; Zeng, Q.; Liu, J.; Ma, X.; Rong, P.; Wang, W. | Feng, Zhichao; Zhao, Huafei; Kang, Wendi; Liu, Qin; Wu, Jianzhen; Bragazzi, Nicola Luigi; Ma, Xiaoqian; Wang, Wei; Rong, Pengfei | 23/12/2020 | The Journals of Gerontology: Series A | 10.1093/gerona/glaa317 | - |
62.481 | The Use of Adjuvant Therapy in Preventing Progression to Severe Pneumonia in Patients with Coronavirus Disease 2019: A Multicenter Data Analysis | Early prediction of disease progression in COVID-19 pneumonia patients with chest CT and clinical characteristics | Feng, Z.; Li, J.; Yao, S.; Yu, Q.; Zhou, W.; Mao, X.; Li, H.; Kang, W.; Ouyang, X.; Mei, J.; Zeng, Q.; Liu, J.; Ma, X.; Rong, P.; Wang, W. | Feng, Zhichao; Yu, Qizhi; Yao, Shanhu; Luo, Lei; Zhou, Wenming; Mao, Xiaowen; Li, Jennifer; Duan, Junhong; Yan, Zhimin; Yang, Min; Tan, Hongpei; Ma, Mengtian; Li, Ting; Yi, Dali; Mi, Ze; Zhao, Huafei; Jiang, Yi; He, Zhenhu; Li, Huiling; Nie, Wei; Liu, Yin; Zhao, Jing; Luo, Muqing; Liu, Xuanhui; Rong, Pengfei; Wang, Wei | 02/10/2020 | Nature Communications | 10.1038/s41467-020-18786-x | - |
119.914 | BCG protects against COVID-19? A word of caution | BCG epidemiology supports its protection against COVID-19? A word of caution | Szigeti, R.; Kellermayer, D.; Kellermayer, R. | Szigeti, Reka; Kellermayer, Domos; Trakimas, Giedrius; Kellermayer, Richard | 07/10/2020 | PLOS ONE | 10.1371/journal.pone.0240203 | CRESS, medRxiv |
127.514 | Associations of clinical characteristics and antiviral drugs with viral RNA clearance in patients with COVID-19 in Guangzhou, China: a retrospective cohort study | Associations of clinical characteristics and treatment regimens with the duration of viral RNA shedding in patients with COVID-19 | Chen, X.; Zhang, Y.; Zhu, B.; Zeng, J.; Hong, W.; He, X.; Chen, J.; Zheng, H.; Qiu, S.; Deng, Y.; Chan, J.; Wang, J. | Chen, Xudan; Zhu, Baoyi; Hong, Wenxin; Zeng, Jianwen; He, Xi; Chen, Jingfeng; Zheng, Haipeng; Qiu, Shuang; Deng, Ying; Chan, Juliana C.N.; Wang, Jian; Zhang, Yuying | 30/06/2020 | International Journal of Infectious Diseases | 10.1016/j.ijid.2020.06.091 | CRESS |
184.463 | Hydroxychloroquine in patients mainly with mild to moderate COVID-19: an open-label, randomized, controlled trial | Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: open label, randomised controlled trial | Tang, W.; Cao, Z.; Han, M.; Wang, Z.; Chen, J.; Sun, W.; Wu, Y.; Xiao, W.; Liu, S.; Chen, E.; Chen, W.; Wang, X.; Yang, J.; Lin, J.; Zhao, Q.; Yan, Y.; Xie, Z.; Li, D.; Yang, Y.; Liu, L.; Qu, J.; Ning, G.; Shi, G.; Xie, Q. | Tang, Wei; Cao, Zhujun; Han, Mingfeng; Wang, Zhengyan; Chen, Junwen; Sun, Wenjin; Wu, Yaojie; Xiao, Wei; Liu, Shengyong; Chen, Erzhen; Chen, Wei; Wang, Xiongbiao; Yang, Jiuyong; Lin, Jun; Zhao, Qingxia; Yan, Youqin; Xie, Zhibin; Li, Dan; Yang, Yaofeng; Liu, Leshan; Qu, Jieming; Ning, Guang; Shi, Guochao; Xie, Qing | 15/05/2020 | BMJ | 10.1136/bmj.m1849 | CRESS, medRxiv |